News tagged with 'Prostate Cancer'

XMRV is a retrovirus that embeds in the body and is linked to both chronic fatigue syndrome and prostate cancer. Whether it is a cause or a correlation remains a mystery.

A virus may be linked to the most aggressive form of prostate cancer. If a test can be developed, it will potentially help identify which cancers should be treated, and which can progress under watchful waiting.

The PSA test for prostate cancer is not specific enough to determine if a cancer is fast growing or not, and as a result, many men are treated aggressively for prostate cancer, which carries its own risks and side effects.

The drug is called denosumab, and it is used to stop the production of cells known as osteoclasts, that breakdown bone causing osteoporosis. Amgen is seeking approval for the new drug but the FDA is concerned the drug also supresses the immune system opening up someone to infections and cancer.

Green tea has been shown to slow the growth of prostate cancer, according to published research from Louisiana State University.  The amount of green tea consumed was equal to a dozen cups per day. 

Men have two options when it comes to having a blood test for prostate cancer and these studies don't make the options any clearer. A PSA blood test may detect some type of cancer early, but the treatment can be worse than the disease.  Experts discuss the recommendations. 

It is an injectable drug that is the first new drug in several years to treat prostate cancer. Degarelix has been approved by the FDA and will begin a rollout in Europe during the first quarter of 2009.  The drug suppresses testosterone production, slowing the growth and progression of prostate cancer.

Adding radiation therapy to standard drug treatment can cut half the death rate from advanced prostate cancer and should become the standard of care globally, suggests Swedish researchers.

Researchers have made the first association that shows genetic variants of a “fat hormone” can affect the risk of colorectal cancer. The study findings published, in the Journal of the American Medical Association, may help researchers to pinpoint those individuals who are at greater risk of developing colorectal cancer.

A new study finds that hormone therapy may not work as effectively in all prostate cancer patients. Researchers say, there is no evidence showing hormones help patients with low-risk or slow growing tumors.

A new study published in the journal Lancet Oncology suggests significant lifestyle changes including a healthier diet and more exercise can help to improve levels of an enzyme that controls cell aging.

Takins NSAIDs pain relievers appears to lower the PSA marker for prostate cancer by about 10 percent. But are NSAIDs reducing the risk of cancer or masking the ability to test for it ? That question is unanswered as the wisdom of even testing for PSA is being debated in larger clinical trials.

In a major breakthrough, scientists have shown that men with high levels of calcium in their blood are almost three times as likely to be killed by fatal prostate cancer.

A definitive answer to solve the dispute - whether aggressive treatment or watchful waiting is preferable in prostate cancer patients - is likely still years away following the results of a decade long European study.

A new report published in the Annals of Internal Medicine advises against regular prostate cancer screenings in men 75 and older, saying the risks far outweigh the benefits for men in that age group.